Market Currents
The marketing partner (Eisai ESALY.PK) for Arena's (ARNA) obesity-fighting Belviq has petitioned...
-
Monday, December 24, 2012, 7:27 AM ETThe marketing partner (Eisai ESALY.PK) for Arena's (ARNA) obesity-fighting Belviq has petitioned the DEA to expedite its approval process. If granted (this sort of request is rarely denied), this could have the drug in pharmacies on February 7, writes Joe Dedvukaj. Combined with what looks to be imminent EU approval, Street analysts will find themselves needing to catch up to lofty sales figures.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 3 comments:
It seems that they took the word of Mr. Cramer instead of performing due diligence.
Institutional buys tells a very different story on Arena.
I am long ARNA and will enjoy an even better Christmas on this news.